Is neratinib following trastuzumab in early-stage HER2-positive breast cancer cost-effective? Meeting Abstract
| Authors: | Schwartz, N. R. M.; Flanagan, M. R.; Babigumira, J. B.; Steuten, L. M. G.; Roth, J. A. |
| Abstract Title: | Is neratinib following trastuzumab in early-stage HER2-positive breast cancer cost-effective? |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 398s |
| Language: | English |
| ACCESSION: | WOS:000487345806179 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.6625 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6625 -- Source: Wos |
